Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Maximilian F. Konig; Alfred H.J. Kim; Marc H. Scheetz; Elizabeth R. Graef; Jean W. Liew; Julia Simard; Pedro M. MacHado; Milena Gianfrancesco; Jinoos Yazdany; Daman Langguth; Philip C. Robinson

doi:10.1136/annrheumdis-2020-217690

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Maximilian F. Konig, Alfred H.J. Kim, Marc H. Scheetz, Elizabeth R. Graef, Jean W. Liew, Julia Simard, Pedro M. MacHado, Milena Gianfrancesco, Jinoos Yazdany, Daman Langguth, Philip C. Robinson

Research output: Contribution to journal › Letter › peer-review

23 Scopus citations

Original language	English
Pages (from-to)	1386-1388
Number of pages	3
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	10
DOIs	https://doi.org/10.1136/annrheumdis-2020-217690
State	Published - Oct 1 2020

Keywords

epidemiology
hydroxychloroquine
lupus erythematosus
pharmacokinetics
systemic

Access to Document

10.1136/annrheumdis-2020-217690

Cite this

Konig, M. F., Kim, A. H. J., Scheetz, M. H., Graef, E. R., Liew, J. W., Simard, J., MacHado, P. M., Gianfrancesco, M., Yazdany, J., Langguth, D., & Robinson, P. C. (2020). Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases, 79(10), 1386-1388. https://doi.org/10.1136/annrheumdis-2020-217690

Konig, Maximilian F. ; Kim, Alfred H.J. ; Scheetz, Marc H. ; Graef, Elizabeth R. ; Liew, Jean W. ; Simard, Julia ; MacHado, Pedro M. ; Gianfrancesco, Milena ; Yazdany, Jinoos ; Langguth, Daman ; Robinson, Philip C. / Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. In: Annals of the Rheumatic Diseases. 2020 ; Vol. 79, No. 10. pp. 1386-1388.

@article{183f4cde721c451ca8b4211eb97eb168,

title = "Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19",

keywords = "epidemiology, hydroxychloroquine, lupus erythematosus, pharmacokinetics, systemic",

author = "Konig, {Maximilian F.} and Kim, {Alfred H.J.} and Scheetz, {Marc H.} and Graef, {Elizabeth R.} and Liew, {Jean W.} and Julia Simard and MacHado, {Pedro M.} and Milena Gianfrancesco and Jinoos Yazdany and Daman Langguth and Robinson, {Philip C.}",

year = "2020",

month = oct,

day = "1",

doi = "10.1136/annrheumdis-2020-217690",

language = "English",

volume = "79",

pages = "1386--1388",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

number = "10",

}

Konig, MF, Kim, AHJ, Scheetz, MH, Graef, ER, Liew, JW, Simard, J, MacHado, PM, Gianfrancesco, M, Yazdany, J, Langguth, D & Robinson, PC 2020, 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19', Annals of the Rheumatic Diseases, vol. 79, no. 10, pp. 1386-1388. https://doi.org/10.1136/annrheumdis-2020-217690

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. / Konig, Maximilian F.; Kim, Alfred H.J.; Scheetz, Marc H.; Graef, Elizabeth R.; Liew, Jean W.; Simard, Julia; MacHado, Pedro M.; Gianfrancesco, Milena; Yazdany, Jinoos; Langguth, Daman; Robinson, Philip C.

In: Annals of the Rheumatic Diseases, Vol. 79, No. 10, 01.10.2020, p. 1386-1388.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

AU - Konig, Maximilian F.

AU - Kim, Alfred H.J.

AU - Scheetz, Marc H.

AU - Graef, Elizabeth R.

AU - Liew, Jean W.

AU - Simard, Julia

AU - MacHado, Pedro M.

AU - Gianfrancesco, Milena

AU - Yazdany, Jinoos

AU - Langguth, Daman

AU - Robinson, Philip C.

PY - 2020/10/1

Y1 - 2020/10/1

KW - epidemiology

KW - hydroxychloroquine

KW - lupus erythematosus

KW - pharmacokinetics

KW - systemic

UR - http://www.scopus.com/inward/record.url?scp=85085133964&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2020-217690

DO - 10.1136/annrheumdis-2020-217690

M3 - Letter

C2 - 32381561

AN - SCOPUS:85085133964

VL - 79

SP - 1386

EP - 1388

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 10

ER -

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Keywords

Access to Document

Other files and links

Cite this